Abbott Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	46,585	44,328	41,950	40,109	43,653	43,075
Revenue Growth (YoY)	8.06%	5.67%	4.59%	-8.12%	1.34%	24.46%
Cost of Revenue	20,212	19,319	18,706	17,975	19,142	18,537
Gross Profit	26,373	25,009	23,244	22,134	24,511	24,538
Selling, General & Admin	13,945	12,332	11,697	10,949	11,248	11,324
Depreciation & Amortization Expenses	1,922	1,682	1,878	1,966	2,013	2,047
Research & Development	3,160	2,942	2,844	2,741	2,888	2,742
Total Operating Expenses	19,027	16,956	16,419	15,656	16,149	16,113
Operating Income	7,346	8,053	6,825	6,478	8,362	8,425
Interest Income	261	308	344	385	183	43
Interest Expense	-415	-493	-559	-637	-558	-533
Other Non-Operating Income (Expense)	618	598	403	438	319	276
Total Non-Operating Income (Expense)	464	413	188	186	-56	-214
Pretax Income	7,511	8,466	7,013	6,664	8,306	8,211
Provision for Income Taxes	2,086	1,942	-6,389	941	1,373	1,140
Net Income	5,425	6,524	13,402	5,723	6,933	7,071
Net Income to Common	5,425	6,524	13,402	5,723	6,933	7,071
Net Income Growth	-61.19%	-51.32%	134.18%	-17.45%	-1.95%	57.31%
Shares Outstanding (Basic)	1,744	1,741	1,740	1,740	1,753	1,775
Shares Outstanding (Diluted)	1,747	1,748	1,748	1,749	1,764	1,789
Shares Change (YoY)	-0.07%	-	-0.06%	-0.85%	-1.40%	0.17%
EPS (Basic)	3.10	3.73	7.67	3.28	3.94	3.97
EPS (Diluted)	3.09	3.72	7.64	3.26	3.91	3.94
EPS Growth	-61.28%	-51.31%	134.36%	-16.62%	-0.76%	57.60%
Free Cash Flow	-	7,395	6,351	5,059	7,804	8,648
Free Cash Flow Growth	-	16.44%	25.54%	-35.17%	-9.76%	51.08%
Free Cash Flow Per Share	-	4.23	3.63	2.89	4.42	4.83
Dividends Per Share	2.480	2.400	2.240	2.080	1.920	1.820
Dividend Growth	3.33%	7.14%	7.69%	8.33%	5.50%	18.95%
Gross Margin	56.61%	56.42%	55.41%	55.18%	56.15%	56.97%
Operating Margin	15.77%	18.17%	16.27%	16.15%	19.16%	19.56%
Profit Margin	11.65%	14.72%	31.95%	14.27%	15.88%	16.42%
FCF Margin	-	16.68%	15.14%	12.61%	17.88%	20.08%
EBITDA	7,346	11,169	10,043	9,721	11,629	11,963
EBITDA Margin	15.77%	25.20%	23.94%	24.24%	26.64%	27.77%
EBIT	7,346	8,053	6,825	6,478	8,362	8,425
EBIT Margin	15.77%	18.17%	16.27%	16.15%	19.16%	19.56%
Effective Tax Rate	27.77%	22.94%	-91.10%	14.12%	16.53%	13.88%

SEC Filings: 10-K · 10-Q